In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units

International Journal of Antimicrobial Agents

Volumn 36, Issue 2, 2010, Pages 191-192

  Özbek, Berna ^a   Ötük, Gülten ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; MEROPENEM; SULBACTAM; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; IN VITRO STUDY; INTENSIVE CARE UNIT; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; CARBAPENEMS; COLISTIN; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; SULBACTAM; THIENAMYCINS;

EID: 77953808684     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.04.004     Document Type: Letter

References (7)

1. Higgins P.G., Dammhayn C., Hackel M., Seifert H. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 2010, 65:233-238.
2. Chastre J., Trouillet J.L. Problem pathogens (Pseudomonas aeruginosa and Acinetobacter). Semin Respir Infect 2000, 15:287-298.
3. Cisneros J.M., Rodríguez-Baño J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 2002, 8:687-693.
4. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Seventeenth informational supplement. Document M100-S17. Wayne, PA: CLSI; 2007.
5. Pillai S.K., Moellering R.C., Eliopoulos G.M. Antimicrobial combinations. Antibiotics in laboratory medicine 2005, 365-440. Lippincott Williams & Wilkins, Philadelphia, PA. V. Lorian (Ed.).
6. National Committee for Clinical Laboratory Standards. Methods for determining a bactericidal activity of antimicrobial agents; approved guideline. Document M26-A. Wayne, PA: NCCLS; 1999.
7. Sader H.S., Jones R.N., Dowzicky M.J., Fritsche T.R. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit. Diagn Microbiol Infect Dis 2005, 52:203-208.